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For nephronophthisis (NPHP), the primary genetic cause of chronic renal failure in young adults, three loci have
been mapped. To identify a new locus for NPHP, we here report on total-genome linkage analysis in seven families
with NPHP, in whom we had excluded linkage to all three known NPHP loci. LOD scores 11 were obtained at
nine loci, which were then fine mapped at 1-cM intervals. Extensive total-genome haplotype analysis revealed
homozygosity in one family, in the region of the PCLN1 gene. Subsequent mutational analysis in this gene revealed
PCLN1 mutations, thereby allowing exclusion of this family as a phenocopy. Multipoint linkage analysis for the
remaining six families with NPHP together yielded a maximum LOD score (Zmax) of 8.9 (at D1S253). We thus
identified a new locus, NPHP4, for nephronophthisis. Markers D1S2660 and D1S2642 are flanking NPHP4 at a
2.9-cM critical interval. In one family with NPHP4, extensive genealogical studies were conducted, revealing con-
sanguinity during the 17th century. On the basis of haplotype sharing by descent, we obtained a multipoint Zmax
of 5.8 for D1S253 in this kindred alone. In addition, we were able to localize to the NPHP4 locus a new locus
for Senior-Løken syndrome, an NPHP variant associated with retinitis pigmentosa.
Introduction
Nephronophthisis (NPHP) comprises a group of auto-
somal recessive cystic renal disorders that constitute the
most common genetic cause of end-stage renal disease
(ESRD) during the first 2 decades of life (Smith and Gra-
ham 1945; Fanconi et al. 1951; Hildebrandt 1999). Fol-
lowing the symptoms of polyuria, polydipsia, anemia, and
growth retardation, ESRD inevitably develops during
childhood or young adulthood, requiring renal-replace-
ment therapy for survival. Three gene loci have been
mapped: those for (i) juvenile nephronophthisis (NPHP1
[MIM 256100]), on chromosome 2q13 (Antignac et al.
1993; Hildebrandt et al. 1993b); (ii) infantile nephron-
ophthisis (NPHP2 [MIM 602088]), on 9q22-q31 (Haider
et al. 1998); and (iii) adolescent nephronophthisis, on
3q21-q22 (NPHP3 [MIM 604387]) (Omran et al. 2000).
Although there is genetic-locus heterogeneity, disease var-
iants are indistinguishable by renal histology, which ex-
hibits a triad of interstitial-cell infiltrates, renal tubular-
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cell atrophy with cysts arising from the cortico-medullary
junction of the kidneys, and renal interstitial fibrosis
(Waldherr et al. 1982). Clinically, there is a statistically
different age at onset at ESRD: terminal renal failure de-
velops at median ages of 1 year, 13 years, and 19 years,
in NPHP2, NPHP1, and NPHP3, respectively (Omran et
al. 2000). We recently identified the causative gene,
NPHP1, for juvenile nephronophthisis (Hildebrandt et al.
1997). The gene product nephrocystin contains an SH3
protein-protein–interaction domain (Otto et al. 2000).
Since nephrocystin interacts with the focal-adhesion com-
ponents p130CAS, tensin, and focal adhesion kinase 2
(Benzing et al. 2001), defects in focal-adhesion signaling
are most likely involved in the pathogenesis of NPHP1
(Hildebrandt andOtto 2000). Associations ofNPHPwith
autosomal recessive retinitis pigmentosa (RP) have been
described as the so-called Senior-Løken syndrome (SLS
[MIM 266900]) (Løken et al. 1961; Senior et al. 1961).
A late-onset form of RP occurs in a small percentage of
patients with NPHP1 mutations without an apparent ge-
notype/phenotype correlation (Caridi et al. 1998). Inter-
estingly, another locus for early-onset SLS (i.e., Leber
congenital amaurosis) colocalizes to the NPHP3 locus
(Omran et al. 2002). We here report chromosomal lo-
calization of a fourth gene locus, NPHP4, for NPHP. In
addition, we localize to the new NPHP4 locus a novel
locus for SLS, termed “SLSN4.”
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Figure 1 Haplotypes on chromosome 1p36 in six families with NPHP4. Eleven microsatellites, from p-ter to cen (top to bottom), are
shown to the left of the pedigrees. Circles denote females; squares denote males; filled symbols indicate affected status. Haplotypes are indicated
by as differently shaded bars. In family F30, the double line indicates consanguinity, and genotypes homozygous by descent in affected individuals
are boxed. Markers flanking the NPHP4 locus, as defined by lack of homozygosity in family F30, are underlined.
Patients and Methods
Blood samples and clinical data for seven families with
NPHP were obtained after informed consent was given
by patients and their parents and siblings. Ethnic origins
of these families were as follows: families F10, F30, and
F158 are German; family F344 is Lebanese; family F444
is Finnish; family F461 is French; and family F698 is
Belgian. The diagnosis of NPHP was made by a pediatric
nephrologist who was the primary physician for these
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Figure 2 Multipoint LOD scores for the NPHP4 locus, versus the 11 markers shown in figure 1, calculated in all six families with NPHP4.
Positions (in cM) are according to the Ge´ne´thon map relative to the position of D1S243 (Dib et al. 1996). The two markers—D1S2660 and
D1S2642—that flank the NPHP4 region (see fig. 1) are underlined. p-ter p p-terminal orientation; cen p centromeric orientation.
patients. Diagnostic criteria were (i) development of
ESRD following a history of polyuria, polydipsia, and
anemia; (ii) renal ultrasound compatible with NPHP;
(iii) a kidney-biopsy result consistent with NPHP; and
(iv) absence of extrarenal symptoms, such as RP, Cogan
syndrome, liver fibrosis, and cone-shaped epiphyses. For
family F461, kidney-biopsy results were not available.
Since there was clearly no doubt regarding the diagnosis
of NPHP in this family, an exception was made, a priori,
to include this family, despite the lack of biopsy data.
In these patients, ESRD commenced within a wide age
range, 11–34 years.
The diagnosis of SLS was made according to the same
criteria, with regard to renal symptoms, as were used
for NPHP. In SLS, these renal symptoms are associated
with RP. Clinical data for family F3 with SLS have been
published previously (Polak et al. 1983): All three af-
fected siblings had RP suggestive of Leber amaurosis
congenita. Individual F3-II-1 had only central areas of
vision and died in 1993, because of complications from
chronic renal failure following renal transplantation.
Individual F3-II-3 had received a cadaveric renal trans-
plant before the age of 28 years. In patient F3-II-7,
reexamination for this study revealed, at age 30 years,
long-standing flat electroretinographic results and cen-
tral tunnel vision of 10, in both eyes. At age 35 years,
visual acuity was reduced to only light perception by
the right eye and hand-movement perception by the left
eye. At the same time, there was ESRD, with a serum
creatinine level raised to 751 mmol/liter.
Genomic DNA was isolated, by standard methods
(Maniatis et al. 1987), either directly from blood sam-
ples or after Epstein-Barr–virus transformation of pe-
ripheral blood lymphocytes (Steel et al. 1977). Individ-
uals were genotyped in a genomewide linkage analysis
using 384 microsatellite markers with an average spac-
ing of 11 cM. For haplotyping at fine resolution, novel
microsatellite markers were generated by running the
program BLAST with sequences of di-, tri-, and tetranu-
cleotides as query against genomic sequence of the re-
spective regions. Semiautomated genotyping was per-
formed by a MegaBACE-1000 analysis system, as
described elsewhere (Saar et al. 1997). Data were an-
alyzed by Genetic Profiler Software, version 1.1. For
two-point and multipoint analyses, genetic maps and
allele numbers were taken from the Ge´ne´thon data (Dib
et al. 1996), with equal allele frequencies being as-
sumed. For marker D1S253, which yielded the maxi-
mum LOD score (Zmax), allele frequency was 0.2. Two-
point LOD-score calculations were performed by the
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Figure 3 Discovery of consanguinity in family F30. Year of birth
is indicated below the symbol for each individual (but, in the last two
generations, is omitted, to ensure anonymity). Note that consanguinity
in the 17th century was detected; tracing of the consanguinity loop
was facilitated by the occurrence of a rare name (“R”) and residence
in a small township (“e”). Symbols are as in figure 1. A slash through
a symbol indicates that the individual is deceased.
LINKAGE program package (Lathrop and Lalouel
1984), with the help of the newly developed LINKRUN
computer program (Saar et al. 1997), using an auto-
somal recessive model with 100% penetrance, a gene
frequency of NPHP, and SLS frequency set at 0.00001
(Potter et al. 1980). For computation of multipoint
LOD scores, the programs VITESSE (O’Connell and
Weeks 1995) and SIMWALK (Barnes et al. 2001) were
used. Haplotyping was performed by GENEHUNTER
(Kruglyak et al. 1996) and, in a total-genome synopsis
of all examined families in tabular form, by Excel 5.0
(Microsoft). The “LODmax  1 support interval” was
defined as the genetic-map positions intersecting the
LOD-score curve at Zmax  1 (Conneally et al. 1985).
For display of genomewide two-point LOD-score data,
the programs MAKESCAN and LODVIEW (Hilde-
brandt et al. 1993a) were used. Graphic display of ped-
igree structure was accomplished by CYRILLIC 2.1
(Cherwell Scientific) and, for multipoint LOD scores,
by Excel 5.0 (Microsoft).
Results
During the past 10 years we ascertained, worldwide, 61
multiplex families with NPHP. In 26 of them, we ex-
cluded NPHP1, on the basis of either absence of mu-
tations in NPHP1 or lack of linkage to this locus (Hil-
debrandt et al. 2001). After exclusion both of families
with extrarenal symptoms and of families compatible
with linkage to either NPHP2 or NPHP3, seven mul-
tiplex families remained, indicating the presence of an
additional, unknown locus for NPHP, with exclusive re-
nal involvement. A total-genome search for linkage was
performed in these seven families. Suggestive LOD scores
12 were obtained on chromosomes 1q and 6q, and LOD
scores 11 were obtained on chromosomes 1p, 3p, 9q,
12p, 16, 17p, and 22q. To extract maximum informa-
tion from the total-genome search, total-genome hap-
lotypes generated by the GENEHUNTER program were
evaluated in tabular form, on the basis of physical-map
order, for regions of compatibility with linkage in at least
four of the seven families with NPHP4. In these regions,
additional markers were haplotyped at fine resolution
of ∼1 cM, partially on the basis of newly generated mi-
crosatellite markers. This led to the identification, in
family F344, of a 62-cM region of homozygosity on
3q29, in the region of the paracellin-1 (PCLN1) gene
(Simon et al. 1999). Further scrutiny revealed that re-
cessive loss-of-function mutations were present in this
gene, thereby identifying this family, on a molecular ge-
netic basis, as a phenocopy actually representingprimary
hypomagnesemia with hypercalciuria and nephrocalci-
nosis (FHHN [MIM 603959]). Thus, we were able, a
posteriori, to exclude family F344 from the study.
By further high-resolution haplotyping, we detected
a chromosome 1p36.31 interval compatible with link-
age for all other six NPHP families (fig. 1). Multipoint
linkage analysis of 11 markers at the NPHP4 locus,
which were calculated together for all six remaining
families with NPHP4, yielded a Zmax of 8.9, for marker
D1S253 at relative position 15.1 (fig. 2). The 95% CI
at Zmax  1 (Conneally et al. 1985) extends over a 2.9-
cM interval between markers D1S2660 and D1S2642
(which are at relative positions 13.1 and 16.0, respec-
tively) (fig. 2).
In family F30, there were two markers found to be
homozygous in affected individuals (fig. 1). We there-
fore inverted the paradigm of homozygosity mapping
(Lander and Botstein 1987), by postulating homozy-
gosity by descent for these individuals (Omran et al.
2002). On both the paternal and the maternal sides of
family F30, we identified an ancestor with a rare sur-
name that occurs only 96 times among 40 million en-
tries in the German online telephone registry. The fact
that both the paternal and the maternal ancestors came
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Figure 4 Haplotypes on chromosome 1p36.31 of family F3 with SLS. Eight microsatellite markers, from p-ter to cen (top to bottom),
are shown to the left of the pedigrees. Symbols are as in figure 1. In each of the affected individuals, the genotypes homozygous by descent are
boxed. The two markers—D1S468 and D1S436—that flank the SLSN4 region are underlined.
from a small township facilitated the tracing of the pos-
tulated consanguinity loop (fig. 3). With the help of
church records, we were able to demonstrate consan-
guinity in family F30, through a common ancestor born
in 1677 (fig. 3). On the basis of consanguinity by de-
scent, the LOD score for family F30 alone was Z pmax
(recombination fraction 0) for marker D1S253. The5.8
existence of shorter loops of consanguinity, however, can-
not be excluded in this kindred. Closer chains of kinship,
as well as the use of higher allele frequencies for markers,
would lower the Zmax attainable, as has been discussed
elsewhere (Omran et al. 2002).
We thus identified a new gene locus, NPHP4, for a
new disease entity of nephronophthisis, NPHP4. Since
markers D1S2660 and D1S2642 are lacking homozy-
gosity by descent in family F30 (fig. 1), they delimit, as
flanking markers, the NPHP4 critical region, to within
a 2.9-cM critical interval of genetic distance. On the
Project Ensembl physical map, this interval measures
∼2.0 Mb (relative marker positions are 4,950,934 and
6,876,371, respectively).
A gene locus for SLS—that is, the association of
NPHP with RP—has been described in patients with
homozygous deletions in the NPHP1 gene (Caridi et al.
1998). In addition, an SLS locus has been colocalized
to NPHP3 (Omran et al. 2002), raising the question of
whether pleiotropic genes at both loci are responsible
for NPHP as well as for SLS phenotypes. We therefore
tested the hypothesis that a gene locus for SLS might
colocalize to the newly identified,NPHP4 locus. In fam-
ily F3, a consanguineous family with SLS (fig. 4) and
with three individuals affected with late-onset RP, ped-
igree structure was sufficient to yield a LOD score 12.
This is sufficient proof of linkage if only a few candidate
regions are examined, thus avoiding the problem of
multiple testing, a problem that is inherent in a total-
genome search for linkage (Ott 1991). In family F3,
haplotype analysis of eight markers at theNPHP4 locus
was compatible with homozygosity by descent in all
three affected children (fig. 4). Multipoint linkage anal-
ysis for these markers yielded a Zmax of 2.7, for marker
D1S214 (data not shown). This marker is positioned,
on a physical map, only 0.3 Mb from marker D1S2642,
which flanks theNPHP4 region on the centromeric side
(fig. 2). We thus identified a new locus, SLSN4, for SLS.
Lack of homozygosity defined markers D1S468 and
D1S436 as flanking markers delimiting a 36.8-cM in-
terval that overlaps with the critical NPHP4 interval
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delimited by markers D1S2660 and D1S2642. The crit-
ical regions for NPHP4 and SLSN4 thus overlap each
other.
The question of whether the phenotypes of NPHP4
with isolated kidney involvement and of SLS4 arise (i)
from the pleiotropic action of one and the same gene
or (ii) from a large homozygous deletion of two neigh-
boring genes can only be answered once the responsible
gene has been identified. In projects of total-genome
analysis for linkage of recessive traits, for which a large
number of pedigrees is difficult to ascertain, the ap-
proach described here might be useful. It includes ex-
traction of complete linkage information by total-ge-
nome haplotyping in tabular form, with consecutive fine
mapping of all regions, in which linkage is not excluded
for at least half of the pedigrees. If fine mapping reveals
homozygosity in affected individuals, then consanguin-
ity, even if remote, should be actively sought.
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